Latham’s Washington, D.C. office offers clients powerhouse corporate capabilities, regulatory insights, as well as litigation and trial strength.
We have built a remarkable track record of navigating the federal government — in the courts, the White House and Executive Branch agencies, as well as Congress. As a group, we draw on experience serving in a wide variety of senior roles within the federal government, so we can advise clients based on deep knowledge of the inner workings of government.
We regularly represent clients facing criminal, civil, and congressional investigations, litigation in all US courts, and the full range of commercial disputes. Our courtroom victories regularly earn Latham recognition from National Law Journal as among the very best litigators and trial lawyers in Washington.
Unique among firms in the capital, we combine classic litigation and regulatory practices with our premier transactional practices, which include the largest and most successful corporate/M&A, capital markets, private equity, and leveraged finance practices in Washington.
As one of the world’s largest pro bono providers, Latham takes on matters in nearly every area of public interest law. In Washington, D.C., some of our key pro bono causes include advocating for asylum seekers, reuniting immigrant and refugee families, and safeguarding tenants’ rights, veterans’ rights, and civil rights.
The firm earned 63 #1 rankings for global energy and infrastructure M&A in 2024.
Latham litigators honored for successful outcomes in New York’s Appellate Division, First Department for Searchlight Capital Partners as well as at the US Internal Trade Commission on behalf of Serendia LLC.
A Latham team led by Mike Morin and David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Finnegan, for their outstanding defense against a US$290 million patent infringement claim and securing a US$116 million award on behalf of Sarepta Therapeutics, in a one-week timed trial in Delaware.